{
    "startDate": "2019-03-01",
    "endDate": "2019-08-31",
    "year": "2020",
    "quarter": "Q2",
    "symbol": "BZYR",
    "data": {
        "bs": [
            {
                "label": "Cash and Cash Equivalents, at Carrying Value",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 1108
            },
            {
                "label": "Prepaid Expense, Current",
                "concept": "PrepaidExpenseCurrent",
                "unit": "usd",
                "value": 44985
            },
            {
                "label": "Assets, Current [Abstract]",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 46093
            },
            {
                "label": "Assets [Abstract]",
                "concept": "Assets",
                "unit": "usd",
                "value": 46093
            },
            {
                "label": "Accounts Payable, Current",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 92917
            },
            {
                "label": "Accrued Liabilities, Current",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 135640
            },
            {
                "label": "Liabilities and Equity [Abstract]",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 228557
            },
            {
                "label": "Commitments and Contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common Stock, Value, Issued",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 131449
            },
            {
                "label": "Additional Paid in Capital, Common Stock",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 122587968
            },
            {
                "label": "Retained Earnings (Accumulated Deficit)",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -122901881
            },
            {
                "label": "Stockholders' Equity Attributable to Parent [Abstract]",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -182464
            },
            {
                "label": "Liabilities and Equity [Abstract]",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 46093
            }
        ],
        "cf": [
            {
                "label": "Net Income (Loss) Available to Common Stockholders, Basic",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -878534
            },
            {
                "label": "Represents the clinical trial expenses that are incurred by the entity which are used in the treatment of cancer during the reporting period.",
                "concept": "bzyr:ClinicalTrialExpensesPaid",
                "unit": "usd",
                "value": 600434
            },
            {
                "label": "Increase (Decrease) in Prepaid Expense",
                "concept": "IncreaseDecreaseInPrepaidExpense",
                "unit": "usd",
                "value": 23521
            },
            {
                "label": "Increase (Decrease) in Accounts Payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -8148
            },
            {
                "label": "Increase (Decrease) in Accrued Liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 27885
            },
            {
                "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -281884
            },
            {
                "label": "Proceeds from Contributed Capital",
                "concept": "ProceedsFromContributedCapital",
                "unit": "usd",
                "value": 282284
            },
            {
                "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 282284
            },
            {
                "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": 400
            }
        ],
        "ic": [
            {
                "label": "Research and Development Expense",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 632469
            },
            {
                "label": "General and Administrative Expense",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 246065
            },
            {
                "label": "Operating Expenses [Abstract]",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 878534
            },
            {
                "label": "Operating Income (Loss)",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -878534
            },
            {
                "label": "Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -878534
            },
            {
                "label": "Net Income (Loss) Available to Common Stockholders, Basic",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -878534
            },
            {
                "label": "Earnings Per Share, Basic and Diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.01
            },
            {
                "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 131448444
            }
        ]
    }
}